Search Results - "Lin, Chih-Lin"

The Usefulness of Metformin and Ganwei for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized, Placebo-Controlled Trial.

Authors: Lin, Chih-Lin Li, Wei-You Wu, Shang-Jung et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 5, p2411. 15p.

Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up.

Authors: Yu, Ming‐Whei Wu, Wan‐Jung Lin, Chih‐Lin et al.

Source: Hepatology Research. Jan2025, Vol. 55 Issue 1, p46-57. 12p.

Letter: vaccination for global control of hepatitis B—from prevention to elimination.

Authors: Lin, Chih‐Lin Kao, Jia‐Horng

Source: Alimentary Pharmacology & Therapeutics. Dec2022, Vol. 56 Issue 11/12, p1627-1628. 2p.

Artificial islands in modern development: Construction, applications, and environmental challenges.

Authors: Wang, Yan-Ning Peng, Jing-Rui Bogireddy, Chandra et al.

Source: Marine Georesources & Geotechnology; Dec2024, Vol. 42 Issue 12, p1896-1906, 11p

Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection.

Authors: Chang, Yu‐Ping Lee, Ji‐Yuh Chen, Chi‐Yi et al.

Source: Alimentary Pharmacology & Therapeutics. May2025, Vol. 61 Issue 9, p1508-1518. 11p.

Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B.

Authors: Yu, Ming-Whei Lin, Chih-Lin Liu, Chun-Jen et al.

Source: Cancers. Dec2022, Vol. 14 Issue 23, p6012. 14p.

End-to-end Go (Weiqi) game record reconstruction from live broadcast videos.

Authors: Lin, Chih-Lin Ou, Hsia-Hung Chen, Lung Hung et al.

Source: Engineering Applications of Artificial Intelligence; Dec2025:Part B, Vol. 162, pN.PAG-N.PAG, 1p

Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study.

Authors: Liu, Chen-Hua Sun, Hsin-Yun Peng, Cheng-Yuan et al.

Source: Open Forum Infectious Diseases. Aug2022, Vol. 9 Issue 8, p1-9. 9p.

Hepatitis B virus: new therapeutic perspectives.

Authors: Lin, Chih-Lin Yang, Hung-Chih Kao, Jia-Horng

Source: Liver International. Jan2016 Supplement, Vol. 36, p85-92. 8p. 1 Diagram, 1 Chart.

Treatment Retention Rates of 3-monthly Paliperidone Palmitate and Risk Factors Associated with Discontinuation: A Population-based Cohort Study.

Authors: Chien-Heng Lin Huang-Li Lin Chih-Lin Chiang et al.

Source: Clinical Psychopharmacology & Neuroscience. 2023, Vol. 21 Issue 3, p544-558. 15p.

Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan.

Authors: Liu, Chen‐Hua Yu, Ming‐Lung Peng, Cheng‐Yuan et al.

Source: Alimentary Pharmacology & Therapeutics. Dec2018, Vol. 48 Issue 11/12, p1290-1300. 11p. 4 Charts, 5 Graphs.

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

Authors: Su, Tung ‐ Hung Hu, Tsung ‐ Hui Chen, Chi ‐ Yi et al.

Source: Liver International. Dec2016, Vol. 36 Issue 12, p1755-1764. 10p. 6 Charts, 2 Graphs.

Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues.

Authors: Tseng, Kuo ‐ Chih Tseng, Chih ‐ Wei Hsieh, Tsai ‐ Yuan et al.

Source: Hepatology Research. Jun2016, Vol. 46 Issue 7, p642-649. 8p.

Switch Function and Pathological Dissociation in Acute Psychiatric Inpatients.

Authors: Chiu, Chui-De Tseng, Mei-Chih Meg Chien, Yi-Ling et al.

Source: PLoS ONE. 4/28/2016, Vol. 11 Issue 4, p1-11. 11p.

Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma.

Authors: Cheng, Hsiang-Yun Kang, Pei-Jen Chuang, Ya-Hui et al.

Source: PLoS ONE. Nov2014, Vol. 9 Issue 11, p1-15. 15p.

Author Index.

Source: Hepatology international Mar2012; Vol. 6 (1).

Journal Info: Publisher: Springer Nature ISSN: 1936-0533

Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial.

Authors: Liu, Chen-Hua Huang, Chung-Feng Liu, Chun-Jen et al.

Source: Scientific Reports. 7/3/2015, p11710. 1p.

Advanced Research on Industry, Information System and Material Engineering, IISME2011

Authors: Helen Zhang Gang Shen David Jin

Resource Type: eBook.

Subjects: Technology--Congresses, Telecommunication--Congresses, Materials--Congresses

Categories: TECHNOLOGY & ENGINEERING / Materials Science / General

An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan.

Authors: Yu ML Tai CM Mo LR et al.

Source: Hepatology international [Hepatol Int] 2024 Apr; Vol. 18 (2), pp. 461-475. Date of Electronic Publication: 2024 Jan 21.

Publication Type: Observational Study; Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN: 19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE

Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma.

Authors: Huang BY Tsai MR Hsu JK et al.

Source: Molecular carcinogenesis [Mol Carcinog] 2020 Nov; Vol. 59 (11), pp. 1269-1279. Date of Electronic Publication: 2020 Sep 10.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE